Popular Education
2023 Revision to USP 797: What Home Infusion Pharmacies Need to Know
On Novemeber 1, 2022 USP released the revised version of General Chapter Pharmaceutical Compounding--Sterile Preparations, which becomes enforceable November 1, 2023.
Treatment of Neurological Disorders with Immunoglobulin Therapy
This program will review the current immunglobulin therapies that are FDA approved for both autoimmune and neurological disorders. 1 CE
Prepare for 2023: Regulatory & Reimbursement Updates
NHIA’s Connie Sullivan and Bill Noyes will focus on recent rules and regulations that members need to be aware to incorporate into their operational plans, billing and coding procedures, and advocacy efforts.
